Guideline | Drug Name |
---|---|
Tysabri (natalizumab) | Tysabri (natalizumab) |
Tzield (teplizumab - mzwv) - PA, NF | Tzield (teplizumab - mzwv) |
Ultomiris (ravulizumab-cwvz) | Ultomiris (ravulizumab-cwvz) |
Unituxin (dinutuximab) | Unituxin (dinutuximab) |
Uplizna (inebilizumab-cdon) | Uplizna (inebilizumab-cdon) |
Upneeq (oxymetazoline hydrochloride) | Upneeq (oxymetazoline hydrochloride ophthalmic solution) |
Urea Cycle Disorder Agents - PA, NF | Buphenyl (sodium phenylbutyrate), Olpruva (sodium phenylbutyrate), Pheburane (sodium phenylbutyrate), Ravicti (glycerol phenylbutyrate) |
Ustekinumab – PA, NF – Standard Default | Stelara IV (ustekinumab), Imuldosa IV (ustekinumab-srlf), Otulfi IV (ustekinumab-aauz), Pyzchiva IV (ustekinumab-ttwe), Selarsdi IV (ustekinumab-aekn), Steqeyma IV (ustekinumab-stba), Yesintek IV (ustekinumab-kfce), Stelara SC (ustekinumab), Imuldosa SC (ustekinumab-srlf), Otulfi SC (ustekinumab-aauz), Pyzchiva SC (ustekinumab-ttwe), Selarsdi SC (ustekinumab-aekn), Steqeyma SC (ustekinumab-stba), Yesintek SC (ustekinumab-kfce) |
Vafseo (vadadustat) - PA, NF | Vafseo (vadadustat) |
Valchlor (mechlorethamine gel) | Valchlor (mechlorethamine gel) |
Vanflyta (quizartinib) | Vanflyta (quizartinib) |
Vanrafia (atrasentan) | Vanrafia (atrasentan) |
Velsipity (etrasimod) | Velsipity (etrasimod) |
Vemlidy (tenofovir alafenamide) - ST, NF | Vemlidy (tenofovir alafenamide tablet) |
Venclexta (venetoclax) | Venclexta (venetoclax) |
Venxxiva (tiopronin delayed-release) | Venxxiva (tiopronin delayed-release) |
Veopoz (pozelimab-bbfg) | Veopoz (pozelimab-bbfg) |
Veozah (fezolinetant) | Veozah (fezolinetant) |
Verkazia (cyclosporine ophthalmic emulsion 0.1%) - PA, NF | Verkazia (cyclosporine ophthalmic emulsion 0.1%) |
Verquvo (vericiguat) | Verquvo (vericiguat) |